Dorothy Darby
Adult Health · Austin, TXNPI 1689671794
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 450 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Pfizer$1K
- Novo Nordisk$879
- Amgen$807
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$749
- Johnson & Johnson$493
- plus $4K from 30 others
What the payments were for
- Food & beverage$9,311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 79 | $1,394 |
| Pfizer | 55 | $1,093 |
| Novo Nordisk | 32 | $879 |
| Amgen | 47 | $807 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 38 | $749 |
| Johnson & Johnson | 29 | $493 |
| AstraZeneca | 20 | $394 |
| Boehringer Ingelheim | 21 | $382 |
| Bayer | 15 | $368 |
| Impulse Dynamics (USA) Inc. | 13 | $357 |
| Abbott | 9 | $344 |
| Alnylam Pharmaceuticals Inc. | 8 | $263 |
| Merck | 15 | $239 |
| E.r. Squibb & Sons, L.L.C. | 9 | $214 |
| Amarin Pharma, Inc. | 9 | $183 |
| Cvrx, Inc. | 10 | $176 |
| Esperion Therapeutics, Inc. | 9 | $156 |
| Shockwave Medical, Inc | 1 | $129 |
| Sanofi-aventis U.S. LLC | 3 | $72 |
| Boston Scientific | 3 | $67 |
| Abiomed | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $45 |
| Baxter Healthcare | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Itamar Medical Inc | 1 | $37 |
| Cardiva Medical, Inc. | 1 | $34 |
| Irhythm Technologies, Inc. | 1 | $31 |
| Atricure, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,311 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 21 | $13,055 |
| EntrestoSacubitril/Valsartan | 11 | $11,813 |
| FarxigaDapagliflozin Propanediol | 13 | $3,827 |
| Ezetimibe | 19 | $952 |
| Metoprolol Succinate | 48 | $530 |
| Nebivolol Hcl | 14 | $432 |
| Atorvastatin Calcium | 36 | $424 |
| Carvedilol | 41 | $252 |
| ClopidogrelClopidogrel Bisulfate | 19 | $232 |
| Rosuvastatin Calcium | 12 | $223 |
| Potassium Chloride | 12 | $152 |
| Losartan Potassium | 16 | $148 |
| Spironolactone | 18 | $144 |
| Lisinopril | 12 | $121 |
| Amlodipine Besylate | 33 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $1,394 | $11,81311 claims |
| AstraZenecaFarxiga | $394 | $3,82713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 933 adult health providers in Texas.
Other adult health in Austin
- Elizabeth Wedberg SivamAustin$71K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Nicole BuschAustin$28K
- Marni MartinezAustin$14K
- Melani DayalAustin$13K
- Laura CalaisAustin$12K
- Shane ConcepcionAustin$10K
- Lauren KissockAustin$9K
- Sarah RayAustin$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.